XML 13 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (17,540) $ (979)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 18,721 19,820
Amortization of deferred financing costs 483 1,848
Credit loss expense   37
Deferred income tax benefit (5,932) (2,056)
Equity-based employee and director compensation expense 205 561
Loss on dispositions and lease terminations, net 16,806 1,767
Changes in operating assets and liabilities, net of acquisitions (6,927) (9,460)
Net cash provided by operating activities 5,816 11,538
Cash flows from investing activities:    
Principal payments received on notes receivable 45 53
Proceeds from sale of assets   568
Capital expenditures (6,105) (6,001)
Lease termination payments to Applegreen, including inventory purchases (19,904)  
Net cash used in investing activities (25,964) (5,380)
Cash flows from financing activities:    
Borrowings under revolving credit facilities 49,000 187,400
Repayments on revolving credit facilities (6,740) (15,537)
Repayments on the Term Loan Facility   (158,980)
Payments of finance lease obligations (744) (698)
Payments of deferred financing costs (74) (6,906)
Distributions paid on distribution equivalent rights (65) (56)
Distributions paid on common units (19,941) (19,918)
Net cash provided by (used in) financing activities 21,436 (14,695)
Net increase (decrease) in cash and cash equivalents 1,288 (8,537)
Cash and cash equivalents at beginning of period 4,990 16,054
Cash and cash equivalents at end of period $ 6,278 $ 7,517